Potential Psychiatric Uses for MDMA

Phase II trials of 3,4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy have demonstrated initial safety and efficacy for treatment of posttraumatic stress disorder (PTSD), with potential for expansion to depression and anxiety disorders. In these trials, single doses of MDMA are administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazar‐Klosinski, BB, Mithoefer, MC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Developments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260336/
https://www.ncbi.nlm.nih.gov/pubmed/27859039
http://dx.doi.org/10.1002/cpt.565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260336/
https://www.ncbi.nlm.nih.gov/pubmed/27859039
http://dx.doi.org/10.1002/cpt.565

Ejemplares similares